Stocks›Healthcare›REGN

REGN

Regeneron Pharmaceuticals, Inc.

NasdaqResearch view

Regeneron Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations industry.

$726.47−1.19%

Oct 5 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsLarge-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 28, 2025 and Oct 31, 2024, before the open.

Last report

Jul 30, 2026+6.17%

before the open

Last 4, next close

median 6.19% either way

up 2 of 4

Every report since 2024 →Earnings calendar →

DateEventSourceNext close

Jul 30Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+6.17%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

22 big days in a year, and what we hold on each

A big day is a close more than 3.21% from the one before, three times REGN’s median day (1.07%). On 5 of the 22, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.21%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayREGNWhat we hold that dayGroup (median of 4) · each

1 Oct 8, 2025−3.32%
Before our storiesgroup −0.2%, did not move with it
1Oct 8, 2025−3.32%
Before our stories
−0.2% did not move with itMRK −1.4 · ABBV −0.7 · LLY +0.3 · JNJ +0.4
2 Oct 28, 2025+11.82%
Resultsgroup −0.9%, did not move with it
2Oct 28, 2025+11.82%
ResultsFirst close after the Oct 28 results filing
−0.9% did not move with itABBV −0.2 · LLY −0.8 · MRK −1.1 · JNJ −1.8
3 Nov 20, 2025+4.87%
Before our storiesgroup −0.3%, did not move with it
3Nov 20, 2025+4.87%
Before our stories
−0.3% did not move with itJNJ +0.3 · MRK −0.1 · LLY −0.6 · ABBV −1.5
4 Nov 25, 2025+3.40%
Before our storiesgroup +2.4%, moved with REGN
4Nov 25, 2025+3.40%
Before our stories
+2.4% moved with REGNMRK +5.2 · LLY +3.7 · ABBV +1.0 · JNJ +0.3
5 Dec 1, 2025−3.86%
Before our storiesgroup −1.4%, did not move with it
5Dec 1, 2025−3.86%
Before our stories
−1.4% did not move with itMRK −2.9 · LLY −1.6 · ABBV −1.1 · JNJ −0.8
6 Dec 10, 2025+4.86%
Before our storiesgroup +1.1%, did not move with it
6Dec 10, 2025+4.86%
Before our stories
+1.1% did not move with itJNJ +3.3 · LLY +1.2 · ABBV +1.0 · MRK +0.8
7 Jan 7, 2026+4.60%
Before our storiesgroup +2.7%, moved with REGN
7Jan 7, 2026+4.60%
Before our stories
+2.7% moved with REGNABBV +4.2 · LLY +4.1 · JNJ +1.3 · MRK −0.3
8 Jan 12, 2026−3.58%
Before our storiesgroup +0.8%, did not move with it
8Jan 12, 2026−3.58%
Before our stories
+0.8% did not move with itMRK −1.2 · ABBV −0.0 · LLY +1.6 · JNJ +2.6
9 Feb 10, 2026−3.25%
Before our storiesgroup −0.4%, did not move with it
9Feb 10, 2026−3.25%
Before our stories
−0.4% did not move with itLLY −1.9 · MRK −0.4 · ABBV −0.4 · JNJ −0.1
10 Mar 12, 2026−3.62%
Before our storiesgroup −0.7%, did not move with it
10Mar 12, 2026−3.62%
Before our stories
−0.7% did not move with itLLY −2.3 · ABBV −1.0 · JNJ −0.4 · MRK −0.3
11 Apr 29, 2026−6.21%
Resultsgroup +0.3%, did not move with it
11Apr 29, 2026−6.21%
ResultsFirst close after the Apr 29 results filing
+0.3% did not move with itLLY −2.6 · JNJ −0.2 · MRK +0.8 · ABBV +3.1
12 May 18, 2026−9.82%
Before our storiesgroup +0.3%, did not move with it
12May 18, 2026−9.82%
Before our stories
+0.3% did not move with itLLY −1.7 · ABBV −0.5 · JNJ +1.0 · MRK +1.1
13 Jun 8, 2026−3.79%
Before our storiesgroup −0.7%, did not move with it
13Jun 8, 2026−3.79%
Before our stories
−0.7% did not move with itABBV −1.8 · MRK −1.1 · JNJ −0.3 · LLY +1.6
14 Jul 2, 2026+4.73%
Nothing on REGNgroup +3.5%, moved with REGN
14Jul 2, 2026+4.73%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+3.5% moved with REGNABBV +4.0 · JNJ +3.6 · MRK +3.3 · LLY +1.9
15 Jul 7, 2026+4.07%
Nothing on REGNgroup +2.3%, moved with REGN
15Jul 7, 2026+4.07%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+2.3% moved with REGNJNJ +3.0 · LLY +3.0 · MRK +1.6 · ABBV −0.0
16 Jul 22, 2026−3.56%
Nothing on REGNgroup −0.1%, did not move with it
16Jul 22, 2026−3.56%
Nothing on REGNNo REGN story, brief or results filing in our record that day
−0.1% did not move with itABBV −1.1 · LLY −1.1 · MRK +1.0 · JNJ +2.0
17 Jul 28, 2026+4.20%
Nothing on REGNgroup +1.4%, did not move with it
17Jul 28, 2026+4.20%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+1.4% did not move with itABBV +2.5 · LLY +1.9 · MRK +0.8 · JNJ +0.3
18 Jul 30, 2026+6.17%
Resultsgroup −3.0%, did not move with it
18Jul 30, 2026+6.17%
ResultsFirst close after the Jul 30 results filing
−3.0% did not move with itMRK −0.4 · ABBV −2.2 · JNJ −3.7 · LLY −4.5
19 Jul 31, 2026+3.29%
Nothing on REGNgroup −0.2%, did not move with it
19Jul 31, 2026+3.29%
Nothing on REGNNo REGN story, brief or results filing in our record that day
−0.2% did not move with itMRK +0.3 · JNJ +0.2 · LLY −0.5 · ABBV −2.5
20 Aug 19, 2026+3.78%
Nothing on REGNgroup +3.6%, moved with REGN
20Aug 19, 2026+3.78%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+3.6% moved with REGNMRK +12.6 · LLY +4.5 · ABBV +2.7 · JNJ +0.8
21 Sep 2, 2026+3.42%
Nothing on REGNgroup +0.9%, did not move with it
21Sep 2, 2026+3.42%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+0.9% did not move with itJNJ +1.5 · MRK +1.2 · ABBV +0.7 · LLY +0.0
22 Sep 28, 2026−4.54%
Nothing on REGNgroup +0.2%, did not move with it
22Sep 28, 2026−4.54%
Nothing on REGNNo REGN story, brief or results filing in our record that day
+0.2% did not move with itMRK −0.1 · LLY +0.1 · JNJ +0.3 · ABBV +0.7

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in REGN’s SEC industry; “moved with REGN” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). REGN reports before the open, so day 1 is that day’s close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Oct 28, 2025

day 1+11.82%day 6+7.29%

Reported Jan 30, 2026

day 1−1.07%day 6+4.81%

Reported Apr 29, 2026

day 1−6.21%day 6−1.46%

Reported Jul 30, 2026

day 1+6.17%day 6+11.03%

Next report: expected late OctoberEstimated from the dates of its last four results filings. Not announced. Since the Jul 30 report: +5.72%. Four reports is a small sample.

Every report since 2024 →

Each line is REGN’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$79.8B

Revenue$14.3B+1.00%

Net income$4.5B

EPS, diluted$41.48+8.20%

Operating margin24.9%

Return on equity14.4%

Debt / equity0.06

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$79.8B

Enterprise Value$78.7B

Income$4.5B

Sales$14.3B

Book/sh$332.68

Cash/sh$33.25

Dividend TTM—

Payout8%

Employees—

IPO—

Quick Ratio3.39

Current Ratio4.13

Debt/Eq0.06

EPS (ttm)$41.48

EPS this Y8.2%

EPS past 3/5Y2.8%

Sales past 3/5Y5.6%

EPS Y/Y TTM8.2%

Sales Y/Y TTM1.0%

Shs Outstand93.96M

ROA11.1%

ROE14.4%

ROIC10.2%

Gross Margin—

Oper. Margin24.9%

Profit Margin31.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$16.1B

FY21

$12.2B

FY22

$13.1B

FY23

$14.2B

FY24

$14.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$16.1B	$12.2B	$13.1B	$14.2B	$14.3B
Gross Profit	—	—	—	—	—
Operating Income	$8.9B	$4.7B	$4.0B	$4.0B	$3.6B
Net Income	$8.1B	$4.3B	$4.0B	$4.4B	$4.5B
Diluted EPS	$71.97	$38.22	$34.77	$38.34	$41.48
Operating Cash Flow	$7.1B	$5.0B	$4.6B	$4.4B	$5.0B
Free Cash Flow	—	—	—	—	—

Same industry

REGN against four drug peers, a year at 100

REGN is up 22.5% in a year. Merck is up 61.8%, Eli Lilly 36.1% and Johnson & Johnson 35.7%. Of these four, only AbbVie (+12.4%) did less. Weekly closes, Oct 3, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

REGN +22.5%. Merck +61.8%, Eli Lilly +36.1%, Johnson & Johnson +35.7%, AbbVie +12.4%. Weekly closes, Oct 3, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in REGN’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.08T JNJ$617.0B ABBV$464.4B MRK$356.0B ABT$168.7B PFE$158.5B VRTX$127.9B BMY$124.9B

Build basket with REGN Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.